References
- Nicolaides KH, Snijders RJ, Cheng HH, Gosden C. Fetal gastro-intestinal and abdominal wall defects: associated malformations and chromosomal abnormalities. Fetal Diagn Therapy 1992;7:102–115.
- Scioscia AL, Pretorius DH, Budorick NE, Cahill TC, Axelrod FT, Leopold GR. Second-trimester echogenic bowel and chromosomal abnormalities. Am J Obstet Gynecol 1992;167:889–894.
- Abdel-Fattah SA, Bhat A, Illanes S, Bartha JL, Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the united kingdom. Prenatal Diagn 2005;25:1028–1031.
- Aboujaoude R, Alvarez J, Ganesh V, Apuzzio J. Is testing for cytomegalovirus and cystic fibrosis indicated in members of a nonwhite pregnant population in whom the fetus has an echogenic bowel? Am J Perinatol 2006;23:319–323.
- Bashiri A, Burstein E, Hershkowitz R, Mazor M. Fetal echogenic bowel by ultrasound: what is the clinical significance? Harefuah 2007;146:964–969, 996–997.
- Benacerraf BR, Chaudhury AK. Echogenic fetal bowel in the third trimester associated with meconium ileus secondary to cystic fibrosis. A case report. J Reprod Med 1989;34:299–300.
- Bianchi DW, Crombleholme TM, D'Alton ME. Fetology: Diagnosis and Management of the Fetal Patient. McGraw-Hill Companies, USA; 2000.
- Lee M, Cook CR, Wilkins I. A new association of second trimester echogenic bowel and metabolic disease of the neonate. J Ultrasound Med 2007;26:1119–1122.
- Estroff JA, Parad RB, Benacerraf BR. Prevalence of cystic fibrosis in fetuses with dilated bowel. Radiology 1992;183:677–680.